Tetra Bio-Pharma Inc. (TBPMQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
Tetra Bio-Pharma Balance Sheet
Financials in millions CAD. Fiscal year is December - November.
Millions CAD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | 2014 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '22 Aug 31, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | Nov '19 Nov 30, 2019 | Nov '18 Nov 30, 2018 | Nov '17 Nov 30, 2017 | 2014 - 2016 |
| Cash & Equivalents | 0.48 | 4.89 | 2.5 | 2.04 | 13.59 | 2.19 | Upgrade
|
| Cash & Short-Term Investments | 0.48 | 4.89 | 2.5 | 2.04 | 13.59 | 2.19 | Upgrade
|
| Cash Growth | -94.36% | 95.38% | 22.72% | -85.00% | 519.47% | 79.96% | Upgrade
|
| Accounts Receivable | - | - | - | - | 0.12 | - | Upgrade
|
| Other Receivables | 1.58 | 0.26 | 0.65 | 0.29 | 0.64 | 0.19 | Upgrade
|
| Receivables | 1.58 | 0.26 | 0.65 | 0.29 | 0.76 | 0.19 | Upgrade
|
| Inventory | - | - | - | - | - | 0.04 | Upgrade
|
| Prepaid Expenses | 0.18 | 0.81 | 0.43 | 0.13 | 0.18 | 0.06 | Upgrade
|
| Other Current Assets | - | - | - | 2.92 | - | - | Upgrade
|
| Total Current Assets | 2.25 | 5.95 | 3.58 | 5.38 | 14.53 | 2.49 | Upgrade
|
| Property, Plant & Equipment | 0.63 | 0.69 | 0.43 | 0.23 | - | - | Upgrade
|
| Long-Term Investments | - | 0.69 | 1.33 | - | - | - | Upgrade
|
| Other Intangible Assets | - | - | 23.19 | 22.96 | 8.64 | 8.65 | Upgrade
|
| Other Long-Term Assets | 0.15 | 0.22 | 0.8 | - | 0.26 | - | Upgrade
|
| Total Assets | 3.02 | 7.55 | 29.34 | 28.57 | 23.43 | 11.14 | Upgrade
|
| Accounts Payable | 7.27 | 4.19 | 4.75 | 1.91 | 2.36 | 0.49 | Upgrade
|
| Accrued Expenses | - | - | - | - | 0.18 | 0.01 | Upgrade
|
| Short-Term Debt | 1.66 | 3.11 | 2 | - | - | - | Upgrade
|
| Other Current Liabilities | - | - | - | 2 | - | - | Upgrade
|
| Total Current Liabilities | 8.93 | 7.3 | 6.75 | 3.92 | 2.54 | 0.5 | Upgrade
|
| Total Liabilities | 8.93 | 7.3 | 6.75 | 3.92 | 2.54 | 0.5 | Upgrade
|
| Common Stock | 93.27 | 91.79 | 71.37 | 56.42 | 34.84 | 9.19 | Upgrade
|
| Additional Paid-In Capital | 18.43 | 15.1 | 4.45 | 3.75 | 3.52 | 2.3 | Upgrade
|
| Retained Earnings | -135.57 | -126.74 | -74.56 | -48.09 | -32.8 | -8.13 | Upgrade
|
| Comprehensive Income & Other | 17.96 | 20.09 | 21.33 | 12.57 | 15.33 | 7.79 | Upgrade
|
| Total Common Equity | -5.91 | 0.25 | 22.59 | 24.65 | 20.89 | 11.16 | Upgrade
|
| Minority Interest | - | - | - | - | - | -0.52 | Upgrade
|
| Shareholders' Equity | -5.91 | 0.25 | 22.59 | 24.65 | 20.89 | 10.64 | Upgrade
|
| Total Liabilities & Equity | 3.02 | 7.55 | 29.34 | 28.57 | 23.43 | 11.14 | Upgrade
|
| Total Debt | 1.66 | 3.11 | 2 | - | - | - | Upgrade
|
| Net Cash (Debt) | -1.18 | 1.77 | 0.5 | 2.04 | 13.59 | 2.19 | Upgrade
|
| Net Cash Growth | - | 254.42% | -75.43% | -85.00% | 519.47% | 79.96% | Upgrade
|
| Net Cash Per Share | -0.00 | 0.00 | 0.00 | 0.01 | 0.09 | 0.02 | Upgrade
|
| Filing Date Shares Outstanding | 423.36 | 401.67 | 283.83 | 212.84 | 162.83 | 123.75 | Upgrade
|
| Total Common Shares Outstanding | 423.36 | 401.67 | 283.83 | 212.84 | 162.83 | 123.75 | Upgrade
|
| Working Capital | -6.68 | -1.35 | -3.17 | 1.47 | 11.98 | 1.99 | Upgrade
|
| Book Value Per Share | -0.01 | 0.00 | 0.08 | 0.12 | 0.13 | 0.09 | Upgrade
|
| Tangible Book Value | -5.91 | 0.25 | -0.6 | 1.7 | 12.25 | 2.52 | Upgrade
|
| Tangible Book Value Per Share | -0.01 | 0.00 | -0.00 | 0.01 | 0.08 | 0.02 | Upgrade
|
| Machinery | - | - | - | 0.25 | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.